Related Experiment Video

Updated: May 16, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Nuclear condensation and cell cycle arrest induced by telomerase siRNA in neuroblastoma cells

Ming-Dar Tsai1, Pei-Rong Chen, Lu-Tai Tien

  • 1Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.

Journal of Neuro-Oncology
|December 15, 2012
PubMed

Insights

Small interfering RNA (siRNA) targeting telomerase effectively reduced neuroblastoma cell viability and promoted cell death. This study suggests siRNA against telomerase as a potential therapy for treating this aggressive childhood cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Neuroblastoma is a pediatric malignant extracranial tumor with poor prognoses, especially in advanced stages or with MYCN amplification.
  • Effective therapeutic strategies for neuroblastoma are urgently needed.
  • Small interfering RNA (siRNA) offers a targeted approach to disrupt gene function by binding to specific messenger RNA (mRNA).

Purpose of the Study:

  • To investigate the anti-proliferative effects of telomerase-targeting siRNA on neuroblastoma cells.
  • To evaluate the impact of telomerase siRNA on neuroblastoma cell viability, apoptosis, and cell cycle progression.

Main Methods:

  • Neuroblastoma cells were treated with or without telomerase siRNA.
  • Cell viability was assessed using the WST-1 assay.
  • Apoptosis was evaluated by DAPI labeling to detect nuclear condensation.
  • Cell cycle analysis was performed using flow cytometry.

Main Results:

  • Telomerase siRNA significantly reduced the viability of neuroblastoma cells.
  • siRNA treatment led to an increased percentage of cells in the sub-G1 phase of the cell cycle, indicative of cell death.
  • DAPI labeling confirmed an increased percentage of condensed DNA in treated cells, supporting apoptotic induction.

Conclusions:

  • Telomerase siRNA demonstrates significant anti-proliferative and pro-apoptotic effects on neuroblastoma cells.
  • Targeting telomerase with siRNA presents a promising therapeutic avenue for neuroblastoma treatment.
  • Further development of telomerase siRNA as a neuroblastoma therapy is warranted.

More Related Videos

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons10:50

Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons

Published on: April 24, 2021

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...